Pivot Pharmaceuticals Inc. Contracts & Agreements
46 Contracts & Agreements
- Business Finance (13 contracts)
- Business Operations (5)
- Human Resources (8)
- Intellectual Property (2)
- Mergers & Acquisitions (1)
- Uncategorized (17)
- 10% Senior Secured Convertible Debentures (CDN$1,375,000) due June 1, 2019 (CD-3) (Filed With SEC on May 3, 2019)
- 10% Senior Secured Convertible Debentures (CDN$1,375,000) due June 1, 2019 (CD-4) (Filed With SEC on May 3, 2019)
- Unanimous Shareholders Agreement with Cartagena Leaf Inc (Filed With SEC on December 19, 2018)
- 10% Senior Secured Convertible Debenture (CDN$1,750,000) due March 2, 2019 (CD-3) (Filed With SEC on November 6, 2018)
- 10% Senior Secured Convertible Debenture (CDN$1,750,000) due March 2, 2019 (CD-4) (Filed With SEC on November 6, 2018)
- Employment Agreement between our company and Patrick Rolfes dated March 1, 2018 (Filed With SEC on March 12, 2018)
- Share Exchange Agreement between our company, Thrudermic, LLC, Dr. Joseph Borovsky and Dr. Leonid Lurya dated March 2, 2018 (Filed With SEC on March 12, 2018)
- Employment Agreement between our company and Joseph Borovsky dated March 1, 2018 (Filed With SEC on March 12, 2018)
- 10% Senior Secured Convertible Debenture (CDN$2,500,000) due March 2, 2019 (CD-1) (Filed With SEC on March 12, 2018)
- 10% Senior Secured Convertible Debenture (CDN$2,500,000) due March 2, 2019 (CD-2) (Filed With SEC on March 12, 2018)
- Share Exchange Agreement between our company, ERS Holdings, LLC and the members of ERS Holdings, LLC dated February 10, 2018 (Filed With SEC on March 12, 2018)
- Royalty Agreement between our company and AquaBrew Inc. dated March 1, 2018 (Filed With SEC on March 12, 2018)
- DEBT SETTLEMENT AGREEMENT (Filed With SEC on December 15, 2017)
- PIVOT SOLMIC COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on December 15, 2017)
- BINDING LETTER OF INTENT TECHNOLOGY LICENSING AGREEMENT (Filed With SEC on December 15, 2017)
- DEBT FORGIVENESS AGREEMENT (Filed With SEC on September 15, 2017)
- DEBT FORGIVENESS AGREEMENT (Filed With SEC on September 15, 2017)
- DEBT FORGIVENESS AGREEMENT (Filed With SEC on September 15, 2017)
- Exchange Agreement between our company, IndUS Pharmaceuticals, Inc. and Pravin Chaturvedi, dated September 11, 2017 (Filed With SEC on September 13, 2017)
- Licensing Agreement between our company and Altum Pharmaceuticals Inc. dated September 12, 2017 (Filed With SEC on September 13, 2017)
- SCHEDULE A JOB DESCRIPTION (Filed With SEC on April 29, 2016)
- SCHEDULE A JOB DESCRIPTION (Filed With SEC on April 29, 2016)
- CONSULTING AGREEMENT (Filed With SEC on April 29, 2016)
- DIRECTOR'S AGREEMENT (Filed With SEC on December 15, 2015)
- DIRECTOR'S AGREEMENT (Filed With SEC on December 15, 2015)
- CONSULTING AGREEMENT (Filed With SEC on December 15, 2015)
- EMPLOYMENT AGREEMENT (Filed With SEC on December 15, 2015)
- AGREEMENT AND PLAN OF MERGER AND ACQUISITION AGREEMENT AMONG PIVOT PHARMACEUTUCALS, INC. AND PIVOT PHARMA U.S. INC. AND INDUS PHARMACEUTICALS, INC., AND SINDU RESEARCH... (Filed With SEC on November 23, 2015)
- DIRECTORS AGREEMENT (Filed With SEC on March 26, 2015)
- DIRECTORS AGREEMENT (Filed With SEC on March 26, 2015)
- DIRECTORS AGREEMENT (Filed With SEC on March 26, 2015)
- CONSULTING AGREEMENT (Filed With SEC on March 26, 2015)
- SUBSCRIPTION AGREEMENT DEBT SETTLEMENT (Filed With SEC on December 16, 2013)
- Consulting Agreement with Wakabayashi Fund LLC dated August 15, 2011 (Filed With SEC on August 29, 2011)
- Non-Exclusive License Agreement with Globe Laboratories Inc. dated June 17, 2008 (Filed With SEC on December 3, 2009)
- Clinical Trial Services Master Agreement with Virtus Clinical Development (Pty) Limited dated March 1, 2009 (Filed With SEC on December 3, 2009)
- Master Service Agreement with Northern Lipids Inc. dated October 2, 2007 (Filed With SEC on December 3, 2009)
- Assignment of Invention (NK-001) dated January 30, 2008 (Filed With SEC on December 3, 2009)
- Assignment of Invention (NK-002) dated April 18, 2008 (Filed With SEC on December 3, 2009)
- Share Subscription of Dr. Ahmad Doroudian dated September 17, 2007 (Filed With SEC on August 7, 2009)
- Non-Exclusive License Agreement with Globe Laboratories Inc. dated June 17, 2008 (Filed With SEC on August 7, 2009)
- Management Consulting Agreement with Penny Green dated April 1, 2009 (Filed With SEC on August 7, 2009)
- Director and Option Agreement with Dr. Kamran Shojania dated July 13, 2009 (Filed With SEC on August 7, 2009)
- Director and Option Agreement with Dr. Maziar Badii dated July 13, 2009 (Filed With SEC on August 7, 2009)
- Shareholders Agreement with Dr. Hassan Salari dated July 24, 2009 (Filed With SEC on August 7, 2009)
- Shareholders Agreement with Francine Salari dated July 24, 2009 (Filed With SEC on August 7, 2009)
